Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition

Journal of Nutritional Biochemistry

Volumn 25, Issue 2, 2014, Pages 157-169

  Koivisto, Hennariikka ^a   Grimm, Marcus O ^b   Rothhaar, Tatjana L ^b   Berkecz, Róbert ^c   Lütjohann D, Dieter ^d   Giniatullina, Rajsa ^a   Takalo, Mari ^a   Miettinen, Pasi O ^a   Lahtinen, Hanna Maija ^a   Giniatullin, Rashid ^a   Penke, Botond ^c   Janáky, Tamás ^c   Broersen, Laus M ^e   Hartmann, Tobias ^b   Tanila, Heikki ^a,f  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF SZEGED   (Hungary)

^d UNIVERSITY OF BONN   (Germany)

^e DANONE RESEARCH   (Netherlands)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Amyloid ; APP processing; Fortasyn; Memory; Nutrition; Olfaction; Omega 3 fatty acid; Phospholipid; Phytosterol

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID; ASCORBIC ACID; BETA SECRETASE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FISH OIL; FOLIC ACID; GAMMA SECRETASE; ICOSAPENTAENOIC ACID; PHYTOSTEROL; PYRIDOXINE; SELENIUM;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; COGNITIVE DEFECT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL BEHAVIORAL TEST; EXPERIMENTAL HYPERACTIVITY; FEMALE; LIPID DIET; LIPID STORAGE; MOUSE; NONHUMAN; PRECURSOR; PROTEIN METABOLISM; SPATIAL LEARNING; TRANSGENIC MOUSE; WILD TYPE;

AMYLOID-Β; APP PROCESSING; FORTASYN; MEMORY; NUTRITION; OLFACTION; OMEGA-3 FATTY ACID; PHOSPHOLIPID; PHYTOSTEROL;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION DISORDERS; DIETARY FATS; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC;

EID: 84892553042     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.09.015     Document Type: Article

References (66)

1. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997, 42(5):776-782.
2. Barberger-Gateau P., Jutand M.A., Letenneur L., Larrieu S., Tavernier B., Berr C., et al. Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur J Clin Nutr 2005, 59(7):817-825.
3. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Wilson R.S., et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003, 60(7):940-946.
4. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Wilson R.S. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005, 62(12):1849-1853.
5. Laitinen M.H., Ngandu T., Rovio S., Helkala E.L., Uusitalo U., Viitanen M., et al. Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement Geriatr Cogn Disord 2006, 22(1):99-107.
6. Dangour A.D., Allen E., Elbourne D., Fletcher A., Richards M., Uauy R. Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study. J Nutr Health Aging 2009, 13(3):198-202.
7. Albanese E., Dangour A.D., Uauy R., Acosta D., Guerra M., Guerra S.S., et al. Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study. Am J Clin Nutr 2009, 90(2):392-400.
8. Devore E.E., Grodstein F., van Rooij F.J., Hofman A., Rosner B., Stampfer M.J., et al. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 2009, 90(1):170-176.
9. Schaefer E.J., Bongard V., Beiser A.S., Lamon-Fava S., Robins S.J., Au R., et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006, 63(11):1545-1550.
10. Lopez L.B., Kritz-Silverstein D., Barrett Connor E. High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study. J Nutr Health Aging 2011, 15(1):25-31.
11. Kroger E., Verreault R., Carmichael P.H., Lindsay J., Julien P., Dewailly E., et al. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am J Clin Nutr 2009, 90(1):184-192.
12. Huang T.L., Zandi P.P., Tucker K.L., Fitzpatrick A.L., Kuller L.H., Fried L.P., et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 2005, 65(9):1409-1414.
13. Samieri C., Feart C., Proust-Lima C., Peuchant E., Dartigues J.F., Amieva H., et al. omega-3 fatty acids and cognitive decline: modulation by ApoEepsilon4 allele and depression. Neurobiol Aging 2011, 32:2317.e13-2317.e22.
14. Yurko-Mauro K., McCarthy D., Rom D., Nelson E.B., Ryan A.S., Blackwell A., et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010, 6(6):456-464.
15. Sinn N., Milte C.M., Street S.J., Buckley J.D., Coates A.M., Petkov J., et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 2012, 107(11):1682-1693.
16. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm T., Basun H., Faxen-Irving G., Garlind A., et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 2006, 63(10):1402-1408.
17. Quinn J.F., Raman R., Thomas R.G., Yurko-Mauro K., Nelson E.B., Van Dyck C., et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010, 304(17):1903-1911.
18. Lim G.P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005, 25(12):3032-3040.
19. Oksman M., Iivonen H., Hogyes E., Amtul Z., Penke B., Leenders I., et al. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 2006, 23(3):563-572.
20. Perez S.E., Berg B.M., Moore K.A., He B., Counts S.E., Fritz J.J., et al. DHA diet reduces AD pathology in young APPswe/PS1 delta E9 transgenic mice: possible gender effects. J Neurosci Res 2010, 88(5):1026-1040.
21. Arendash G.W., Jensen M.T., Salem N., Hussein N., Cracchiolo J., Dickson A., et al. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience 2007, 149(2):286-302.
22. Arsenault D., Julien C., Tremblay C., Calon F. DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS One 2011, 6(2):e17397.
23. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004, 43(5):633-645.
24. Kariv-Inbal Z., Yacobson S., Berkecz R., Peter M., Janaky T., Lutjohann D., et al. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol. J Alzheimers Dis 2012, 28(3):667-683.
25. Grimm M.O., Kuchenbecker J., Grosgen S., Burg V.K., Hundsdorfer B., Rothhaar T.L., et al. Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. J Biol Chem 2011, 286(16):14028-14039.
26. Sahlin C., Pettersson F.E., Nilsson L.N., Lannfelt L., Johansson A.S. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease. Eur J Neurosci 2007, 26(4):882-889.
27. Ma Q.L., Teter B., Ubeda O.J., Morihara T., Dhoot D., Nyby M.D., et al. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. J Neurosci 2007, 27(52):14299-14307.
28. Hossain S., Hashimoto M., Katakura M., Miwa K., Shimada T., Shido O. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells. J Neurochem 2009, 111(2):568-579.
29. Florent S., Malaplate-Armand C., Youssef I., Kriem B., Koziel V., Escanye M.C., et al. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J Neurochem 2006, 96(2):385-395.
30. Wang P.Y., Chen J.J., Su H.M. Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression. J Nutr Biochem 2010, 21(4):345-350.
31. Hooijmans C.R., Rutters F., Dederen P.J., Gambarota G., Veltien A., van Groen T., et al. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol Dis 2007, 28(1):16-29.
32. Holguin S., Martinez J., Chow C., Wurtman R. Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J 2008, 22(11):3938-3946.
33. Sakamoto T., Cansev M., Wurtman R.J. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 2007, 1182:50-59.
34. Wurtman R.J., Ulus I.H., Cansev M., Watkins C.J., Wang L., Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 2006, 1088(1):83-92.
35. Nitsch R.M., Blusztajn J.K., Pittas A.G., Slack B.E., Growdon J.H., Wurtman R.J. Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A 1992, 89(5):1671-1675.
36. Pettegrew J.W., Panchalingam K., Hamilton R.L., McClure R.J. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 2001, 26(7):771-782.
37. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298(5594):789-791.
38. de Wilde M.C., Penke B., van der Beek E.M., Kuipers A.A., Kamphuis P.J., Broersen L.M. Neuroprotective effects of a specific multi-nutrient intervention against Abeta42-induced toxicity in rats. J Alzheimers Dis 2011, 27(2):327-339.
39. Broersen L.M., Kuipers A.A., Balvers M., van Wijk N., Savelkoul P.J., de Wilde M.C., et al. A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AbetaPPswe/PS1dE9 mice. J Alzheimers Dis 2013, 33(1):177-190.
40. Scheltens P., Twisk J.W., Blesa R., Scarpini E., von Arnim C.A., Bongers A., et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis 2012, 31(1):225-236.
41. Scheltens P., Kamphuis P.J., Verhey F.R., Olde Rikkert M.G., Wurtman R.J., Wilkinson D., et al. Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial. Alzheimers Dement 2010, 6(1):1,10.e1.
42. Mongrand S., Stanislas T., Bayer E.M., Lherminier J., Simon-Plas F. Membrane rafts in plant cells. Trends Plant Sci 2010, 15(12):656-663.
43. Garcia-Alloza M., Robbins E.M., Zhang-Nunes S.X., Purcell S.M., Betensky R.A., Raju S., et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 2006, 24(3):516-524.
44. Minkeviciene R., Ihalainen J., Malm T., Matilainen O., Keksa-Goldsteine V., Goldsteins G., et al. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice. J Neurochem 2008, 105(3):584-594.
45. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 2004, 13(2):159-170.
46. Rothhaar T.L., Grosgen S., Haupenthal V.J., Burg V.K., Hundsdorfer B., Mett J., et al. Plasmalogens inhibit APP processing by directly affecting gamma-secretase activity in Alzheimer's disease. Scientific World Journal 2012, 2012:141240.
47. Matyash V., Liebisch G., Kurzchalia T.V., Shevchenko A., Schwudke D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 2008, 49(5):1137-1146.
48. Nourooz-Zadeh J., Tajaddini-Sarmadi J., Wolff S.P. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994, 220(2):403-409.
49. Giniatullin A.R., Grishin S.N., Sharifullina E.R., Petrov A.M., Zefirov A.L., Giniatullin R.A. Reactive oxygen species contribute to the presynaptic action of extracellular ATP at the frog neuromuscular junction. J Physiol 2005, 565(Pt 1):229-242.
50. Kemppainen S., Rantamaki T., Jeronimo-Santos A., Lavasseur G., Autio H., Karpova N., et al. Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiol Aging 2012, 33:1122.e23-1122.e39.
51. Mesholam R.I., Moberg P.J., Mahr R.N., Doty R.L. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998, 55(1):84-90.
52. Wesson D.W., Borkowski A.H., Landreth G.E., Nixon R.A., Levy E., Wilson D.A. Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's beta-amyloidosis mouse model. J Neurosci 2011, 31(44):15962-15971.
53. Cassano T., Romano A., Macheda T., Colangeli R., Cimmino C.S., Petrella A., et al. Olfactory memory is impaired in a triple transgenic model of Alzheimer disease. Behav Brain Res 2011, 224(2):408-412.
54. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001, 21(12):4183-4187.
55. Abdul H.M., Sultana R., St Clair D.K., Markesbery W.R., Butterfield D.A. Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. Free Radic Biol Med 2008, 45(10):1420-1425.
56. Du H., Guo L., Yan S., Sosunov A.A., McKhann G.M., Yan S.S. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 2010, 107(43):18670-18675.
57. Sundaram J.R., Chan E.S., Poore C.P., Pareek T.K., Cheong W.F., Shui G., et al. Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J Neurosci 2012, 32(3):1020-1034.
58. Vanmierlo T., Weingartner O., van der Pol S., Husche C., Kerksiek A., Friedrichs S., et al. Dietary intake of plant sterols stably increases plant sterol levels in the murine brain. J Lipid Res 2012, 53(4):726-735.
59. Griffiths S., Scott H., Glover C., Bienemann A., Ghorbel M.T., Uney J., et al. Expression of long-term depression underlies visual recognition memory. Neuron 2008, 58(2):186-194.
60. Warburton E.C., Koder T., Cho K., Massey P.V., Duguid G., Barker G.R., et al. Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory. Neuron 2003, 38(6):987-996.
61. Miranda M.I., Ortiz-Godina F., Garcia D. Differential involvement of cholinergic and beta-adrenergic systems during acquisition, consolidation, and retrieval of long-term memory of social and neutral odors. Behav Brain Res 2009, 202(1):19-25.
62. Baxter M.G., Bucci D.J., Sobel T.J., Williams M.J., Gorman L.K., Gallagher M. Intact spatial learning following lesions of basal forebrain cholinergic neurons. Neuroreport 1996, 7(8):1417-1420.
63. Fanselow M.S. Contextual fear, gestalt memories, and the hippocampus. Behav Brain Res 2000, 110(1-2):73-81.
64. Laparra J.M., Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res 2010, 61(3):219-225.
65. Kankaanpää P., Yang B., Kallio H., Isolauri E., Salminen S. Effects of polyunsaturated fatty acids in growth medium on lipid composition and on physicochemical surface properties of Lactobacilli. Applied and Environmental Microbiology 2004, 70:129-136.
66. Ayesh R., Weststrate J.A., Drewitt P.N., Hepburn P.A. Safety evaluation of phytosterol esters. Part 5. Faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food Chem Toxicol 1999, 37(12):1127-1138.